Metabolic profiles of androgens in malignant human liver cell lines

Annals of the New York Academy of Sciences

Volumn 1089, Issue , 2006, Pages 262-267

  Granata, Orazia M ^a   Cocciadiferro, Letizia ^a   Miceli, Vitale ^a   Polito, Lucia M ^a   Campisi, Ildegarda ^a   Carruba, Giuseppe ^a  

^a ARNAS Civico   (Italy)

Author keywords

5 androgens; 5 androgens; Aromatase; EST; HCC cells

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; AROMATASE; TESTOSTERONE; ESTROGEN; ETHINYLESTRADIOL 17 ALPHA SULFOTRANSFERASE; ETHINYLESTRADIOL-17 ALPHA SULFOTRANSFERASE; SULFOTRANSFERASE; UNCLASSIFIED DRUG;

ANDROGEN METABOLISM; CANCER CELL CULTURE; CELL STRAIN HEPG2; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; REGULATORY MECHANISM; TESTOSTERONE METABOLISM; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; DRUG EFFECT; LIVER TUMOR; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANDROGENS; ANDROSTENEDIONE; AROMATASE; CELL LINE, TUMOR; CELL PROLIFERATION; ESTROGENS; HUMANS; LIVER NEOPLASMS; SULFOTRANSFERASES; TESTOSTERONE;

EID: 33847775188     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1386.028     Document Type: Conference Paper

References (11)

1. TANAKA, K., H. SAKAI, et al. 2000. Serum testosterone:estradiol ratio and the development of hepatocellular carcinoma among male cirrhotic patients. Cancer Res. 60: 5106-5110.
2. MING-WHEI Y., Y. YU-CHING, et al. 2001. Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. J. Natl. Cancer Inst. 93: 1644-1651.
3. GRANATA, O.M., G. CARRUBA, et al. 2002. Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness. Mol. Cell. Endocrinol. 193: 51-58.
4. DEMYAN, W.F., C.S. SONG, et al. 1992. Estrogen sulfotransferase in the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. Endocrinology 6: 589-597.
5. VESSELINOVITCH, S.D., L. ITZE, et al. 1980. Modifying role of partial hepatectomy and gonadectomy in ethylnitrosurea-induced hepatocarcinogenesis. Cancer Res. 40: 1538-1542.
6. KEMP, C.J., C.N. LEARY & N.R. DRINKWATER. 1989. Promotion of murine hepatocarcinogenesis by testosterone is androgen receptor-dependent but not cell autonomous. Proc. Natl. Acad. Sci. USA 86: 7505-7509.
7. CASTAGNETTA, L.A.M., B. AGOSTARA, et al. 2003. Local estrogen formation by nontumoral, cirrhotic, and malignant human liver tissues and cells. Cancer Res. 63: 5041-5045.
8. AGARWAL, V.R., K. TAKAYAMA, et al. 1998. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J. Clin. Endocrinol Metab. 83: 1797-1800.
9. CASTAGNETTA, L., O.M. GRANATA, et al. 1991. A simple approach to measure metabolic pathways of steroids in living cells. J. Chromatogr. 572: 25-39.
10. CASTAGNETTA, L., O.M. GRANATA, et al. 1997. Product of aromatase activity in intact LNCaP and MCF-7 human cancer cells. J. Steroid Biochem. Mol. Biol. 61: 287-292.
11. CASTAGNETTA, L., G. CARRUBA, et al. 2003. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 30: 2597-2605.